Skip to main content
SpringerLink
Log in

Alemtuzumab

Acute inflammatory demyelinating polyneuropathy, treated with immune globulin: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Castelli R, Gritti G, Cannavo A, Moreo G, Conti G, Reda G, Cortelezzi A.Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy: Clinical report of three patients. Immunopharmacology and Immunotoxicology 34: 717-720, No. 4, Aug 2012. Available from: URL: http://dx.doi.org/10.3109/08923973.2011.644295 - Italy

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alemtuzumab. React. Wkly. 1420, 6 (2012). https://doi.org/10.2165/00128415-201214200-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214200-00023

Keywords

Search

Navigation